4563 Share Price Performance
JP¥60.00
11.00 (22.45%)
Price JP¥60.00
Share Pricen/a
AnGes, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
4563 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
AnGes, Inc. Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Feb 10, 2026
- -66.21
- 39.00%
- -3,136.92%
- 0%
About 4563
- Founded
- 1999
- Employees
- 55
- CEO
- WebsiteView website
AnGes, Inc. engages in the research and development of gene-based medicine. It develops HGF gene therapy product for the treatment of chronic arterial occlusive disease; NF-?B decoy oligonucleotide for chronic discogenic lumbar back pain; and DNA vaccines for the treatment of hypertension, as well as tie2 agonists for COVID-19/ARDS, as well as drugs for chronic hepatitis B. The company was formerly known as AnGes MG, Inc. and changed its name to AnGes, Inc. in July 2017. AnGes, Inc. was incorporated in 1999 and is headquartered in Ibaraki, Japan.
